Clinical trial
Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the…
NCT00076817 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00076817 |
|---|---|
| Title | Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm |
| Official title | A Phase I Double Blind Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of the Aventis Pasteur ALVAC-HIV (vCP205) Administered to the Groin Area Versus the Deltoid Area |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Seronegativity |
| Intervention type | Biological |
| Interventions | ALVAC-HIV (vCP205) |
| Enrollment | 18 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Feb 6, 2004 |
| Last update posted | Oct 29, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: